Contract Manufacturing, Drug Substance, API

July 2nd 2024

This collaboration aims to support and accelerate clinical development of advanced and novel technologies.

October 16th 2023

A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.

August 22nd 2023

The collaboration partner for Willow is focused on more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste, in addition to looking for Willow’s expertise in developing and scaling key ingredients.

August 22nd 2023

The deal is worth up to $36 million with an initial upfront consideration of $14 million, with an additional $22 million in contingent value rights (CVRs) that is payable upon achieving certain milestones.